AVAH Maintained by Barclays -- Price Target Raised to $15.00

gurufocus.com · 2026-08-28

On October 24, 2023, Barclays maintained an Overweight rating on Aveanna Healthcare Holdings (AVAH). Analyst Andrew Mok has raised the price target from $9.50 t

TickrTrends take: Barclays raised its price target for AVAH to fifteen dollars, signaling analyst confidence in the company's near-term prospects within the Healthcare sector. Given TickrTrends' current undervalued assessment, this analyst action provides external validation that the market may not be fully pricing in AVAH's value. Investors monitoring the stock should track whether this price target adjustment gains traction among other analysts covering the Healthcare company.

Read the full story at gurufocus.com →